Rhythm Pharmaceuticals (RYTM) revenue

Revenue · fiscal 2025
$189.76M

Rhythm Pharmaceuticals (RYTM) reported revenue of $189.76M in fiscal 2025 (the year ended December 31, 2025). That is 45.8% higher than the $130.13M of fiscal 2024. Figures as of 18 Nov 2026, 05:24 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$189.76M
Change on fiscal 2024
+45.8%
Highest on record
$189.76Mfiscal 2025
Lowest on record
$3.15Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Rhythm Pharmaceuticals revenue, in more detail

Across the 5 fiscal years on record (2021–2025), the highest was $189.76M in fiscal 2025 and the lowest $3.15M in fiscal 2021.

History · 5 fiscal years

Revenue by fiscal year

Rhythm Pharmaceuticals revenue, year by year

Rhythm Pharmaceuticals (RYTM) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$189.76M 45.8% up
2024$130.13M 68.1% up
2023$77.43M 227.6% up
2022$23.64M 649.5% up
2021$3.15M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Rhythm Pharmaceuticals and comparable companies
CompanyRevenueFiscal year
Rhythm Pharmaceuticals RYTM$189.76M2025
Alkermes ALKS$1.48B2025
PACS Group PACS$5.29B2025
Kiniksa Pharmaceuticals International KNSA$677.56M2025
ImmunityBio IBRX$113.29M2025
Cytokinetics CYTK$88.04M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RYTM

Rhythm Pharmaceuticals, figure by figure

Rhythm Pharmaceuticals (RYTM) overview: price, valuation and scorecardAll health care companies by market value

Rhythm Pharmaceuticals revenue: questions and answers

What is Rhythm Pharmaceuticals's revenue?

Rhythm Pharmaceuticals (RYTM) reported revenue of $189.76M in fiscal 2025 (the year ended December 31, 2025). That is 45.8% higher than the $130.13M of fiscal 2024.

What are the highest and lowest revenue figures on record for Rhythm Pharmaceuticals?

Across the 5 fiscal years on record (2021–2025), the highest was $189.76M in fiscal 2025 and the lowest $3.15M in fiscal 2021.

How is Rhythm Pharmaceuticals's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Rhythm Pharmaceuticals (RYTM) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RYTM/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.